Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Hajjar, M.D, Katherine A.
Автор Nachman, M.D, Ralph L.
Дата выпуска 1996
dc.description ▪ Abstract  Lipoprotein(a) [Lp(a)] represents an important independent risk factor for atherosclerotic cardiovascular disease. Lp(a) constitutes a class of low-density lipoprotein-like particles that are structurally heterogenous due to variability within the distinguishing apoprotein, apolipoprotein(a) [Apo(a)]. Apo(a) bears a high degree of homology to the fibrinolytic zymogen, plasminogen, the parent molecule of the serine protease plasmin. Apo(a) contains a variable number of tandemly repeated triple-loop units called kringles, which appear to mediate Lp(a)'s interactions with fibrin and cell surface receptors. Although the mechanism of its atherogenicity is unknown, Lp(a) has been implicated in the delivery of cholesterol to the injured blood vessel, in blockade of plasmin generation on fibrin and cell surfaces, and as a stimulus for smooth muscle cell proliferation. In addition, new members of the plasminogen/Apo(a) gene family have been defined, creating a potential link between Lp(a) and the control of angiogenesis in both health and disease. Pharmacologic therapy of elevated Lp(a) levels has been only modestly successful; apheresis remains the most effective therapeutic modality.
Формат application.pdf
Издатель Annual Reviews
Копирайт Annual Reviews
Название THE ROLE OF LIPOPROTEIN(a) IN ATHEROGENESIS AND THROMBOSIS
DOI 10.1146/annurev.med.47.1.423
Print ISSN 0066-4219
Журнал Annual Review of Medicine
Том 47
Первая страница 423
Последняя страница 442
Аффилиация Hajjar, M.D, Katherine A.; Departments of Pediatrics and Medicine, Cornell University Medical College, 1300 York Avenue, New York, New York 10021

Скрыть метаданые